Jubilant Life falls 6% as USFDA recommends action on failing inspection
newsdepo.com
The stock dipped 6% to Rs 742 on the BSE after the US health regulator recommended a regulatory or administrative action after the inspection of the drug firm's Roorkee manufacturing facility.Jubilant Life falls 6% as USFDA recommends action on failing inspection
The stock dipped 6% to Rs 742 on the BSE after the US health regulator recommended a regulatory or administrative action after the inspection of the drug firm's Roorkee manufacturing facility. Read more